Characterisation of a novel group B oncolytic adenovirus, ColoAd1

<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...

Celý popis

Podrobná bibliografie
Hlavní autor: Di, Y
Další autoři: Seymour, L
Médium: Diplomová práce
Jazyk:English
Vydáno: 2011
Témata: